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Abstract
Objective: The phenomena manifested during inflammation require interplay between circulating effector cells,
local resident cells, soluble mediators and genetic host factors to establish, develop and maintain itself. Of the
molecues involed in the initiation and perpetuation of acute allergic inflammation in asthma, the involvement of
effector cells in redox reactions for producing O2
- (superoxide anion) through the mediation of NADPH oxidase is a
critical step. Prior data suggest that reactive oxygen species (ROS) produced by NADPH oxidase homologues in
non-phagocytic cells play an important role in the regulation of signal transduction, while macrophages use a
membrane-associated NADPH oxidase to generate an array of oxidizing intermediates which inactivate MMPs on or
near them.
Materials and Methods and Treatment: To clarify the role of gp91phox subunit of NADPH oxidase in the
development and progression of an acute allergic asthma phenotype, we induced allergen dependent
inflammation in a gp91
phox-/- single knockout and a gp91phox-/-MMP-12-/- double knockout mouse models.
Results: In the knockout mice, both inflammation and airway hyperreactivity were more extensive than in wildtype
mice post-OVA. Although OVA-specific IgE in plasma were comparable in wildtype and knockout mice, enhanced
inflammatory cell recruitment from circulation and cytokine release in lung and BALf, accompanied by higher
airway resistance as well as Penh in response to methacholine, indicate a regulatory role for NADPH oxidase in
development of allergic asthma. While T cell mediated functions like Th2 cytokine secretion, and proliferation to
OVA were upregulated synchronous with the overall robustness of the asthma phenotype, macrophage
upregulation in functions such as proliferation, and mixed lymphocyte reaction indicate a regulatory role for
gp91phox and an overall non-involvement or synergistic involvement of MMP12 in the response pathway
(comparing data from gp91phox-/- and gp91phox-/-MMP-12-/- mice).
Introduction
Asthma is a complex syndrome with well described
pathology. However, animal and clinical studies in
humans continue to provide conflicting data on contri-
bution of local cells viz. airway epithelial, endothelial
and smooth muscle cells, fibroblasts etc vs. cells
recruited from circulation. Asthma is characterized by
accumulation of inflammatory cells in the lung and air-
ways, secretion of predominantly Th2 cytokines in the
lung and airways, epithelial desquamation, goblet cell
hyperplasia, mucus hypersecretion and thickening of
submucosa resulting in bronchoconstriction and airway
hyperresponsiveness. Dysregulated immunity seems to
suppress Th1 response and triggers Th2 response whose
development is promoted by antigen presenting cells.
Th2 cytokines (IL-4, 5, 9, 13) from these cells of which
IL-4 and 13 promote B cell differentiation into plasma
cells that secrete IgE. Cross-linking of IgE receptors on
mast cell sreleases histamines, prostaglandins, throm-
boxane and leukotrienes leading to bronchoconstriction,
vasodilation and mucus secretion. A cascade of interac-
tions between cells and soluble molecules result in
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hyperresponsiveness.
The production of superoxide anions (O2
-)b yn e u t r o -
phils and other phagocytes is an important step in our
body’s innate immune response. O2
- is the precursor of
a range of chemicals generally referred to as ROS (reac-
tive oxygen species) [1]. These act as microbicidal agents
and kill invading micro-organisms either directly or
through the activation of proteases [2,3]. O2
- is pro-
duced by the NADPH oxidase, a multi-protein enzyme
complex, which is inactive in resting phagocytes, but
becomes activated after interaction of the phagocyte
with pathogens and their subsequent engulfment in the
phagosome [4]. Defects in the function of the NADPH
oxidase result in a severe immunodeficiency, and indivi-
duals suffering from CGD (chronic granulomatous dis-
ease), a rare genetic disorder that is caused by
mutations in NADPH oxidase genes, are highly suscepti-
ble to frequent and often life-threatening infections by
bacteria and fungi [5]. The microbicidal activity of ROS
has generally been seen as the only beneficial function
of these chemicals, and uncontrolled production of ROS
has been implicated in tissue destruction and a number
of disease states. However, over the last couple of years,
it has become apparent that ROS produced by NADPH
oxidase homologues in non-phagocytic cells also play an
important role in the regulation of signal transduction,
often via modulation of kinase and phosphatase activ-
ities or through gene transcription [6]. These NADPH
oxidase homologues are referred to as Nox enzymes
(gp91
phox is specified as Nox2; where phox is phagocytic
oxidase), and several members of this novel protein
family have been identified so far.
There is increasing evidence that redox regulation of
transcription, particularly activator protein-1 (AP-1) and
nuclear factor kappa B (NF-B), is important in inflam-
matory diseases. NADPH oxidase, the primary source of
reactive oxygen species is a strong candidate for the
development of therapeutic agents to ameliorate inflam-
mation and end-organ damage. The possibility of gene
therapy for inherited diseases with a single gene muta-
tion had been verified by the successful treatment with
bone marrow transplantation. As the gene therapy
method and theory has been progressing rapidly, it is
expected that gene therapy will overcome the complica-
tions of bone marrow transplantation. Of these inherited
diseases, chronic granulomatous disease (CGD) is one of
the most expected disease for gene therapy. CGD is an
inherited immune deficiency caused by mutations in any
of the following four phox genes encoding subunits of
the superoxide generating phagocyte NADPH oxidase. It
consists of membranous cytochromeb558 composed of
gp91 phox and p22 phox, and four cytosolic compo-
nents, p47 phox, p67 phox, rac p21 and p40 phox,
which translocate to the membrane upon activation.
The gp91
phox subunit (also called the b-subunit of the
cytochrome) consists of 570 amino acids and has a
molecular mass of 65.3 kDa, but runs as a broad smear
of approx. 91 kDa on SDS/polyacrylamide gels due to a
heterogeneous glycosylation pattern of three asparagine
residues (Asn
132, Asn
149 and Asn
240)[ 7 ]
The N-terminal 300 amino acids are predicted to form
six transmembrane a-helices, while the C-terminal cyto-
plasmic domain contains the binding sites for FAD and
NADPH, shown experimentally through cross-linking
studies and the observation that relipidated flavocyto-
chrome alone can generate O2
- . In addition, gp91
phox is
responsible for complexing the two non-identical haem
groups of the NADPH oxidase via two histidine pairs.
Hence gp91
phox contains all co-factors required for the
electron transfer reaction which occurs in two steps.
First, electrons are transferred from NADPH on to FAD
and then to the haem group in the second step to
reduce O2 to O2
- in a one-electron-transfer reaction. At
present, no information is available on the three-dimen-
sional structure of gp91
phox or fragments thereof,
although a model for the structure of the cytoplasmic
domain of gp91
phox has been suggested based on
sequence homology with the FNR (ferredoxin-NADP
reductase) family [8]. Significant insight into the topol-
ogy of the cytochrome and the sites of interaction with
other oxidase components has been gained through the
use of a number of techniques, including epitope map-
ping or random sequence peptide phage analysis. Addi-
tionally, the study of cytochrome isolated from patients
with X-linked CGD has contributed to our current
understanding of its function [9].
Involvement of the gp91phox subunit in oxidative
b u r s tr e s p o n s eb yP M N sa sw e l la sM js is not clear.
Macrophages use a membrane-associated NADPH oxi-
dase to generate an array of oxidizing intermediates. In
some studies, it has been demonstrated that oxidants
potently and efficiently inactivate matrilysin (MMP-7)
by cross-linking adjacent tryptophan-glycine residues
within the catalytic domain of the enzyme. These in
vitro observations suggest that MMP inactivation can
occur on or near phagocytes that produce both MMPs
and reactive intermediates. In the absence of reactive
intermediates, unrestrained proteolytic activity might
lead to detrimental tissue damage. Indeed, inherited
deficiency of gp91
phox, a phagocyte-specific component
of the NADPH oxidase required for oxidant production,
and targeted deletion of its mouse homologue result in
granuloma formation and excessive tissue destruction
[10]. Aberrant regulation of MMP activity may contri-
bute to the damage that occurs when phagocytes are
unable to generate oxidants. gp91
phox mutant mice were
found to develop spontaneous, progressive emphysema,
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Macrophages and neutrophils use membrane-associated
NADPH oxidase to generate reactive oxygen intermedi-
ates. The initial product of the NADPH oxidase is
superoxide, which is converted into oxidizing oxygen
and nitrogen species. Because their characteristic end
products have been detected in diseases ranging from
atherosclerosis to neurodegenerative disorders, reactive
oxygen and nitrogen intermediates are thought to con-
tribute to inflammatory tissue injury. However, humans
and animals deficient in phagocyte NADPH oxidase
tend to form granulomas and to have excessive tissue
destruction and an exuberant inflammatory response,
raising the possibility that oxidants derived from white
cells actually govern or suppress inflammation.
One potential mechanism whereby reactive oxygen
species can influence inflammation and the associated
tissue damage is by regulating the activity of MMPs. In
addition to their ability to act on extracellular matrix,
MMPs can affect inflammation by directly or indirectly
regulating the activity of inflammatory mediators such
as chemokines. Because reactive intermediates effectively
inactivate MMPs in vitro, they provide an efficient
mechanism for inhibiting unregulated catalysis by these
extracellular proteinases, thereby preventing pathological
destruction of tissue proteins and exuberant inflamma-
tion. Production of reactive intermediates by the phago-
cyte NADPH oxidase could confine MMP activity in
space and time, permitting only bursts of pericellular
proteolysis.
This study endeavours to address the relationship
between gp91phox and MMP in the onset and establish-
ment of acute allergic asthma in a mouse model using
genetic knockout mice, gp91phox-/- which will be
referred to as NOX-/- and MMP12NOX double
knockout.
Materials and methods
Mice
Both gp91
phox-/- mice [11] (Jackson Laboratories, Bar
Harbor, ME) and mmp12
-/- mice [12] were on a
C57Bl/6J background and had been outcrossed and
then intercrossed for three generations to generate ani-
mals deficient in both genes. C57BL6 mice (Taconic)
were used as the control group and are called wildtype.
In total the following number of animals were used in
each group: n for Control groups were WT (wildtype)
14, NOX-/- (gp91phox -/-) 14, DKO (double knockout
MMP12NOX-/-) 16 and n for OVA treated groups
were respectively 16, 15, and 14. Mortality was less
than 1%. Animals were maintained under strict SPF
conditions following guidelines set down by the Uni-
versity of Washington IUCAC under protocol numbers
21-6404 and 2437-05.
Allergen sensitization and challenge
Mice were sensitized and later challenged with OVA
(Pierce, Rockford, IL) as described previously [13,14].
Mice were immunized with OVA (100 μg) complexed
with aluminium sulfate in a 0.2-ml volume, administered
by i.p. injection on day 0. On days 8 (250 μgo fO V A )
and on days 15, 18, and 21 (125 μg of OVA), mice were
anesthetized briefly with inhalation of isoflurane in a
standard anesthesia chamber and given OVA by intra-
tracheal (i.t.) administration. Intratracheal challenges
were done as described previously (Iwata A, JI, 2001).
Mice were anesthetised and placed in a supine position
on the board. The animal’s tongue was extended with
lined forceps and 50 μl of OVA(in the required concen-
tration) was placed at the back of its tongue. The con-
trol goup received normal saline with aluminium sulfate
by i.p. route on day 0 and 0.05 ml of 0.9% saline by i.t.
route on days 8, 15, 18, and 21.
Pulmonary function test
In vivo airway hyperresponsiveness to methacholine was
measured 24 hours after the last OVA challenge by both
invasive and non-invasive plethysmography.
Invasive plethysmography
On d 22, 24 h after the last intra-tracheal allergen
(OVA) challenge invasive pulmonary mechanics were
measured in mice in response to methacholine in the
same manner as previously described [13]with the fol-
lowing modifications: a) the thorax was not opened, b)
mice were ventilated with a tidal volume of 200 μla n d
respiratory rate of 120 breaths/min using a MiniVent
Ventilator for Mice (Harvard Apparatus, Holliston,
MA), c) mice received aerosolized solutions of metha-
choline (0, 3.125, 6.25, 12.5, 25, 50, and 100 mg/ml in
normal saline) via an AER 1021 nebulizer aerosol system
(Buxco Electronics, Inc., Wilmington, NC) with 2.5-4
micron aerosol particle size generated by NEB0126
nebulizer head (Nektar Therapeutics, San Carlos, CA),
and d) a commercial plethysmography system (Model
PLY4111 plethysmograph, MAX II amplifier and pres-
sure transducer system, and Biosystem XA software,
B u x c oE l e c t r o n i c s ,I n c . )w a su s e dt od e t e r m i n eR L as
calculated from measures of pressure and flow and
expressed as cmH2O/ml/s). Non-invasive plethysmogra-
phy (expressed as Penh) was also assessed on d 22 in
independent experiments.
Non-invasive whole body plethysmography in con-
scious, free moving, spontaneously breathing mice using
whole-body plethysmography (model PLY 3211; Buxco
Electronics, Sharon, CT) as previously described [14]
Mice were challenged with aerosolized saline or increas-
ing doses of methacholine (5, 20, and 40 mg/ml) gener-
ated by an ultrasonic nebulizer (DeVilbiss Health Care,
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striction was expressed as enhanced pause(Penh), a cal-
culated dimensionless value, which correlates with the
measurement of airway resistance, impedence, and intra-
pleural pressure in the same mouse. Penh readings were
taken and avergared for 4 min after each nebulization
challenge. Penh was calculated as follows: Penh =[ ( T e /
Tr-1)X (PEF/PIF), where Te is expiration time, Tr is
relaxation time, PEF is peak expiratory flow, and PIF is
peak inspiratoy flow × 0.67 co-efficient. The time for
the box pressure to change from a maximum to a user-
defined percentage of the maximum represents the
relaxation time. The Tr measurement begins at the max-
imum box pressure and ends at 40%.
BAL
After pulmonary function testing, the mouse underwent
exsanguination by intra-orbital arterial bleeding and
then BAL (0.4 ml three times) of both lungs. Total BAL
fluid cells were counted from a 50 μl aliquot and the
remaining fluid was centifuged at 200 g for 10 min at 4°
C and the supernatants stored at -70°C for assay of BAL
cytokines later. The cell pellets were resuspended in
FCS and smears were made on glass slides. The cells,
after air drying, were stained with Wright-Giemsa (Bio-
chemical Sciences Inc, Swedesboro, NJ) and their differ-
ential count was taken under a light microscope at 40 ×
magnification. Cell number refers to that obtained from
lavage of both lungs/mouse.
Lung parenchyma
Lung mincing and digestion was performed after lavage
as described previously (Labarge S et al) with 100 u/ml
collagenase for 1 hr at 37°C, and filtered through a 60#
sieve (Sigma). All numbers mentioned in this paper
refer to cells obtained from one lung/mouse.
Lung histology
Lungs of other animals of same group were were fixed
in 4% paraformaldehyde overnight at 4°C. The tissues
were embedded in paraffin and cut into 5 μms e c t i o n s .
A minimum of 15 fields were examined by light micro-
scopy. The intensity of cellular infiltration around pul-
monary blood vessels was assessed by Hematoxylin and
Eosin staining. Airway mucus was identified by staining
with Alcian blue and Periodic Acid Schiff staining as
described previously [14].
Fluorescin-activated cell sorter (FACS) analysis
Cells from hemolysed peripheral blood (PB), bone mar-
row(BM), bronchoalveolar lavage (BAL), lung parench-
yma (LP), spleen, mesenteric lymph nodes (MLN),
cervical lymph nodes (CLN), axillary lymph nodes
(LNX) and inguinal lymph nodes (LNI) were analyzed
on a FACSCalibur (BD Immunocytometry Systems, San
Jose, CA) by using the CELLQuest program. Staining
was performed by using antibodies conjugated to fluor-
escin isothiocyanate (FITC), phycoerythrin (PE), allo-
phucocyanin (APC), Peridinin Chlorophyll Protein (Per
CP-Cy5.5) and Cy-chrome (PE-Cy5 and PE-Cy7). The
following BD pharmingen (San Diego, CA) antibodies
were used for cell surface staining: APC-conjugated
CD45 (30F-11), FITC-conjugated CD3(145-2C11), PE-
Cy5 conjugated CD4 (RM4-5), PE-conjugated CD45RC
(DNL-1.9), APC-conjugated CD8(53-6.7), PE-Cy5 conju-
gated B220 (RA3-6B2), FITC-conjugated IgM, PE-conju-
gated CD19 (ID3), PE-conjugated CD21(7G6), FITC-
conjugated CD23 (B3B4), APC-conjugated GR-1(RB6-
8C5), and PE-conjugated Mac1(M1/70). PE-Cy5 conju-
gated F4/80 (Cl:A3-1(F4/80)) was obtained from Serotec
Ltd., Oxford, UK. PE-conjugated anti-a4i n t e g r i n( P S 2 )
and anti-VCAM-1(M/K-2) was from Southern Biotech-
nology, Birmingham, Ala. Irrelevant isotype-matched
antibodies were used as controls.
CFU-c assay
To quantitate committed progenitors of all lineages,
CFU-C assays were performed using methylcellulose
semisolid media (Stemgenix, Amherst, N.Y.) supple-
mented with an additional 50 ng of stem cell factor
(Peprotech, Rocky Hill, N.J.) per ml. Next, 50,000 cells
from bone marrow, 500,000 cells from spleen, 0.01
million cells from lung and BAL, and 10 μlp e r i p h e r a l
blood were plated on duplicate 35-mm culture dishes
and then incubated at 37°C in a 5% CO2-95% air mix-
ture in a humidified chamber for 7 days. Colonies gen-
erated by that time were counted by using a dissecting
microscope, and all colony types (i.e., burst forming
units-erythroid [BFU-e], CFU-granulocyte-macrophage
[CFU-GM], and CFU-mixed [CFU-GEMM]) were
pooled and reported as total CFU-C. Total CFU-c per
organ was calculated by extrapolating CFU-c against
number of plated cells to the total number of cells in
the organ.
ELISA for cytokines
Th2 cytokines (IL-4 and 5) and TNFa and IFNg in BAL
and serum (previously frozen at -80°C) were outsourced
to Linco plex Biomarker Immunoassays, Millipore. IL-13
was measured by Quantikine M kits from R&D Systems,
Minneapolis, MN.
OVA specific IgE and IgG1 in serum
Anti-mouse IgE (R35-72) and IgG1(A85-1) from BD
Biosciences, San Diego, CA were used for measuring
OVA specific IgE and IgG1 (in serum previously frozen
at -70°C) respectively by standard ELISA procedures as
previously described [14].
Banerjee and Henderson Clinical and Molecular Allergy 2012, 10:2
http://www.clinicalmolecularallergy.com/content/10/1/2
Page 4 of 14Statistical analysis
Statistical differences among samples were tested by
Student t test. P value less than 0.05 was considered sta-
tistically significant.
Results
Effect of gp91
phox deletion on development of composite
asthma phenotype
Composite asthma phenotype developed completely and
more aggressively in both gp91phox-/- and MMP12-
gp91phox double knockout mice post OVA treatment
as described in Figure 1. Inflammation in terms of total
inflammatory migration (measured by FACS of surface
marker expression and differential count of H&E stained
cytospin smears) was increased (Table 1). In bone mar-
row, NOX-/- post OVA has 1.4-fold more cells (data
not shown), in peripheral blood, 1.3-fold more cells,
spleen had 1.3-fold more cells (data not shown), lung
parenchyma had 1.8-fold more cells, and BALf: 2-fold
more cells compared to post-OVA WT. Of note, 2.4-
fold more PMNs, 1.96-fold more B lymphocytes, 5-fold
more eosinophils in post-OVA NOX-/- and DKO com-
pared to post-OVA WT BAlf was found. Overall sys-
temic response, inflammatory recruitment from blood to
inflammation in lung is more (Table 1).
Pulmonary function test
Pulmonary function test measured by both non-invasive
plethysmographt and invasive plethysmography (Figure
2A-C) show 2.5-fold increase in Penh values compared
to WT post-OVA at 100 mg/ml dose of methacholine.
1.89 and 1.35-folds increase was found in gp91phox-/-
and DKO respectively at 100 mg/ml dose of methacho-
line compared to WT post-OVA by invasive plethysmo-
graphy of anesthetized mice.
Cellularity in bone marrow, blood, lungs and airways
Cellularity was increased in post-OVA mice compared
to saline treated mice. Figure 3 shows 1.8-fold and 1.7-
fold increase in number of cells in lung parenchyma and
BALF and 1.4-fold in spleen in both KO mice than WT.
Recruitment index (Table 2) was increased in B cells,
monocytes, PMNs, Eosinophils and basophils in both
KO mice post-OVA compared to post-OVA WT.
Progenitors in bone marrow, blood, lungs and airways
Table 2 and Figure 4 shows decrease in number of col-
ony forming units in post-OVA bone marrow and lung
of both KO mice compared to similarly treated WT.
Progenitor number was however somewhat upregulated
in both KO groups post-OVA compared to Post-OVA
WT.
Inflammation in the lungs
Histopathology showed a marked increase in peri-
bronchiolar and perivascular infiltration of inflammatory
cells post-OVA in both KO mice compared to control
(Figure 5A-C). The photomicrographs show a marked
increase in both number of inflammatory cells and
mucus secretion in airways.
Airway goblet cell metaplasia
1.27-fold and 1.22-fold increase in percent metaplastic
goblet cells (Figure 6) was measured by counting under
light microscope, the blue mucus laden cells around air-
ways vs. the pink squamous cells which do not show
metaplasia.
Th2 cytokine release in airway
Cytokine concentrations present in the BALf was mea-
sured by ELISA. Figure 7 shows 2.75-fold increase in
OVA 
i.p. 
Plethysmography/BALf/
PB/BM/Lung tissue 
OVA 
i.t. 
0 8  15  18  21  22 
Days of treatment 
Figure 1 Study design to generate acute allergic asthma phenotype in mice: Mice were sensitized with OVA (100 μg) complexed with
aluminium sulfate in a 0.2-ml volume, administered by i.p. injection on day 0 and later challenged with OVA On days 8 (250 μg of OVA) and on
days 15, 18, and 21 (125 μg of OVA), (Pierce, Rockford, IL) by intra-tracheal instillation. Mice were immunized with OVA (100 μg) complexed with
aluminium sulfate in a 0.2-ml volume, administered by i.p. injection on day 0. The control group received normal saline with aluminium sulfate
by i.p. route on day 0 and 0.05 ml of 0.9% saline by i.t. route on days 8, 15, 18, and 21. They were sacrificed on d22. The abbreviations used are:
i.p. intra-peritoneal; i.t. intra-tracheal; BAL, bronchoalveolar lavage; PB, peripheral blood.
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to WT post-OVA. All other Th2 cytokines showed
values similar to post-OVA WT BALf. Data shows
that actual mRNA upregulation was 1.4-fold for IL-4
gene and 1.9-fold for IL-13 genes which are Th2 speci-
fic. There was also upregulation in IL-1a,I L - 1 0a n d
IL-12a, the dignificance of which is not clear at this
point. cells secreting these are T cells, macs and some
Table 1 Number of cells (× 10
6) of leucocyte subsets in peripheral blood, lung parenchyma and bronchoalveolar
lavage fluid (BALf).
BLOOD Leukocyte subsets (× 10
6) in blood, lungs and BAL fluid post OVA treatment.
Total
WBCs
Lymphocytes Monocytes Neutrophils Eosinophils Basophils
CD3+ B220+
WA 11.9 ± 2.4 5.54 ± 1.17 3.08 ± 1.05 0.38 ± 0.185 3.648 ± 0.184 0.223 ± 0.014 0.066 ± 0.001
WO 24.72 ± 6.41 7.31 ± 1.31 5.93 ± 1.17 1.62 ± 0.35 7.97 ± 1.14 0.74 ± 0.36 1.05 ± 0.02
NOXA 14.2 ± 3.012 5.7 ± 1.865 2.99 ± 1.033 0.77 ± 0.053 4.56 ± 1.074 0.133 ± 0.043 0.028 ± 0.002
NOXO 25.625 ±
4.063
6.186 ± 1.076 6.742 ± 0.964 2.424 ± 1.076 8.741 ± 0.064 1.061 *±
0.004
0.556 ± 0.003
DKOA 11.7 ± 2.76 4.69 ± 1.06 2.467 ± 0.96 0.63 ± 0.12 3.74 ± 1.27 0.106 ± 0.07 0.02 ± 0.001
DKOO 27.56 ± 2.79 6.61 ± 1.49 7.27 ± 2.01 2.6 ± 0.47 9.39 ± 2.44 1.14 * ± 0.46 0.59 ± 0.14
Lungs
Total Lymphocytes Monocytes Neutrophils Eosinophils Basophils/ Mj
WBCs CD3+ B220+ Mast cells
WA 1.86 ± 0.543 0.179 ± 0.021 0.035 ± 0.002 0.826 ± 0.054 0.319 ± 0.054 0 0 0.497 ± 0.015
WO 12.35 ± 3.96 4.87 ± 1.05 0.09 ± 0.01 0.37 ± 0.09 1.47 ± 0.43 2.22 ± 0.76 0.046 ± 0.012 3.09 ± 1.08
NOXA 5.49 # ±
1.064
0.446 # ±
0.002
0.113 # ±
0.001
2.593 # ± 0.76 0.892 # ±
0.011
001.489 # ±
0.016
NOXO 22.6 * ±
7.544
4.084 ± 1.075 1.29 * ± 0.643 3.171 * ±
1.075
4.337 * ±
1.074
4.102 * ±
1.066
0.089 * ±
0.002
5.682 ± 0.064
DKOA 3.78 # ± 1.07 0.3 ± 0.14 0.07 ± 0.01 1.78 # ± 0.54 0.61 ± 0.02 0.001 ± 0.0001 0 1.02 # ± 0.29
DKOO 21.66 * ± 408 3.89 ± 1.06 0.43 * ± 0.16 3.03 * ± 0.89 4.16 * ± 1.33 3.93 * ± 1.13 0.08 * ± 0.002 5.44 * ± 1.26
BAL fluid (2 lungs)
WA 0.8 ± 0.013 0 0 0.013 ± 0.004 0 0 0 0.787 ± 0.011
WO 9.46 ± 0.89 1.64 ± 0.21 1.54 ± 0.021 1.26 ± 0.03 0.86 ± 0.01 4.26 ± 0.07 0.04 ± 0.002 0.56 ± 0.004
NOXA 0.63 ± 0.018 0 0 0.014 ± 0.002 0 0 0 0.616 ± 0.003
NOXO 16 * ± 3.159 2.04 ± 0.754 1.213 ± 0.003 2.08 ± 0.074 2.427 * ±
1.066
6.741 * ±
2.076
0.051 ± 0.001 1.568 * ± 0.72
DKOA 0.865 ± 0.01 0 0 0.025 ± 0.002 0 0 0 0.84 ± 0.18
DKOO 15.89 *± 4.03 2 ± 0.86 1.22 ± 0.66 2.05 ± 0.75 2.415 *± 1.01 6.67 *± 1.14 0.05± 0.003 1.55 *± 0.63
Number of cells (× 10
6) of leucocyte subsets in peripheral blood, lung parenchyma and bronchoalveolar lavage fluid (BALf).
T cells B cells Monocytes Neutrophils Eosinophils Basophils
Lungs WO 0.6 0.015 0.22 0.18 3 0.04
NOXO 0.6 0.19* 1.3 0.49* 3.8 0.16*
DKOO 0.58 0.05 1.1 0.44* 3.4 0.13*
BALf WO 0.22 0.25 0.77 0.107 5.75 0.03
NOXO 0.32 0.17 0.85 0.27* 6.3 0.09
DKOO 0.51 0.16 0.78 0.26* 5.8 0.08
Total white blood cells were counted by a Beckman Coulter particle counter and subsets quantified using specific antibody staining in FACS and corroborated by
morphological assessment by light microscopy and also by hemavet using the specifics of mouse. The table shows data averaged from three independent
experiments ± SEM. * denotes p value < 0.05 compared to values from post-OVA wildtype mice and # denotes p value < 0.05 compared to alum treated
wildtype. Abbreviations used are: WA = wildtype +alum, WO = wildtype + OVA, NOXA = gp91phox-/- + alum, NOXO = gp91phox-/- + OVA, DKOA = MMP12-
gp91phox double knockout + alum, DKOO = MMP12-gp91phox double knockout + OVA. (n = 5/group). Recruitment index: Inflammatory hematopoietic cells
found in lungs and BALf expressed as a fraction of corresponding cells in circulation. Number of cells (× 10
6) in lungs and BALf were the numerator and the
number of cells (× 10
6) in circulating blood was the denominator in the fraction calculated to show recruitment index or inflammatory cells recruited from
circulation to lung parenchyma and airways in response to the OVA allergic challenge. * denotes statistically significant change (p value < 0.01)
Banerjee and Henderson Clinical and Molecular Allergy 2012, 10:2
http://www.clinicalmolecularallergy.com/content/10/1/2
Page 6 of 14epithelial cells. Overall, IL-4: NOX-/- post OVA has
1.2-fold more protein and 2-fold more mRNA; IL-5:
NOX-/- post OVA has 2-fold more protein and 2.8-
fold more mRNA; IL-13: NOX-/- post OVA has 3-fold
more protein and 5.6-fold more mRNA. Therefore,
both by protein concentration and mRNA expression,
Th2 cytokines show manifold increase in gp91phox-/-
post-OVA compared to WT.
Functionality of B cells
B cell function was tested by measuring OVA-specific
IgE and IgG1 in post-OVA WT and the two KO mice.
Figure 8 shows that the values are comparable.
Discussion
Phagocytes play a critical role in host defense by produ-
cing reactive oxygen species against invading
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Figure 2 Pulmonary function testing. A. Airway resistance in WT vs. gp91phox-/-. Symbols used are white triangle WA (Wildtype alum), black
circles WO (WT OVA), white cross in black box NOX (alum gp91phox-/-) and black box NOXO (OVA treated gp91phox-/-). Airway resistance
obtained by invasive plethysmography show increased values in both gp91phox-/- and gp91phoxMM12 double knockout mice compared to
wildtype post-OVA. Symbols used are open square WA, closed square WO, open triangle DKOA (alum double knockout), closed triangle DKOO
(OVA treated DKO. On d 22, 24 h after the last intra-tracheal allergen (OVA) challenge invasive pulmonary mechanics were measured using a
commercial plethysmography system (Model PLY4111 plethysmograph, MAX II amplifier and pressure transducer system, and Biosystem XA
software, Buxco Electronics, Inc.) mice receiving aerosolized solutions of methacholine (0, 3.125, 6.25, 12.5, 25, 50, and 100 mg/ml in normal saline)
via an AER 1021 nebulizer aerosol system (Buxco Electronics, Inc., Wilmington, NC) with 2.5-4 micron aerosol particle size generated by NEB0126
nebulizer head (Nektar Therapeutics, San Carlos, CA), and RL as calculated from measures of pressure and flow and expressed as cmH2O/ml/s was
determined. Figures show Airway resistance (RL) values ± SEM of data obtained from 3 independent experiments (n = 5/group). C. Non-invasive
plethysmography (expressed as Penh) was also assessed on d 22 in independent experiments with gp91phox-/- only and this co-related with the
airway resistance values obtained by invasive plethysmography. Symbols used are black diamond WA, open triangle NOX, small black square WO,
open large square NOXO: For non-invasive plethysmography, mice were challenged with increasing doses of aerosolized methacholine (0, 5, and
20, 40, and 100 mg/ml in normal saline) generated by an ultrasonic nebulizer (DeVilbiss Health Care, Inc., Somerset, PA) for 2 min. and the degree
of bronchoconstriction was expressed as enhanced pause (Penh), a calculated dimensionless value that correlates with measurement of airway
resistance, impedance, and intrapleural pressure. Penh is primarily independent of FRC, tidal volume, and respiratory rate since the ratio of
measurements is obtained during the same breath and has a strong correlation with both airway resistance (Raw) measured directly in
anesthetized, tracheotomized, and mechanically ventilated mice. *denotes p value < 0.01 compared to post-OVA wildtype values.
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Page 7 of 14microorganisms. One of the most important enzymes in
producing microbicidal oxidants is the superoxide (O2
2)-generating NADPH oxidase.1 The NADPH oxidase is
a multicomponent enzyme complex whose redox center
is a membrane-associated flavocytochrome b558 hetero-
dimer composed of gp91phox and p22phox. In addition,
three cytosolic oxidase subunits, p47phox,p 6 7 phox,a n d
a low molecular weight GTP binding protein Rac, are
required for high level production of O2 2. In resting
phagocytes, the dormant oxidase is unassembled. How-
ever, upon phagocyte activation, the active oxidase
complex is rapidly formed by translocation of the cyto-
solic oxidase components to the plasma membrane via
interactions with the cytochrome.2 Subsequently, elec-
trons are transferred from cytosolic NADPH to molecu-
lar oxygen (O2) at the external face of the membrane to
generate superoxide anion [15].
In activated neutrophils, a membrane-bound NADPH-
dependent oxidase generates high levels of superoxide, a
process traditionally called “respiratory burst”.I nu n s t i -
mulated neutrophils, components of the NADPH oxi-
dase complex are separated in cytosol (p40phox,
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Figure 3 Increase in total cell number in lung and BALf of knockout mice compared to post-OVA WT. Cell number was counted using a
Z1 particle counter from Beckman Coulter. Bone marrow cells (BM) was flushed out of two femurs, blood (PB) was obtained by infra-orbital
bleeding and extrapolated to a 2 ml volume as the total volume of blood in a 20 gm mouse, from the volume of blood actually obtained,
perfused lung was minced and digested with collagenase IV and single cell suspension made of both lungs, and brochoalveolar lavage fluid
(BALf) was obtained from both lungs, and the cell numbers counted. The data shown have been derived from 3 independent experiments and
expressed as mean values ± SEM. *denotes p value < 0.01 compared to post-OVA wildtype values. Abbreviations used are: WT = wildtype, NOX
= gp91phox-/-, DKO = gp91phox-MMP12 double knockout, WA = WT+alum, WO = WT+OVA, NOXA = gp91phox-/-+alum, NOXO = gp91phox-/-
+OVA, DKOA = gp91phox-MMP12 double knockout+alum, DKOO = gp91phox-MMP12 double knockout+OVA.
Table 2 Clonogenic potential of progenitors
PB/2 ml BM/2femurs LP/2lungs BAL/2lungs Spleen
WA 5371.6 ± 188.6 17034.5 ± 158.8 241.93 ± 11.8 3.15 ± 2.13 75858.9 ± 523.5
WO 16915.6 ± 219.1 57161.5 ± 161.9 11225.4 ± 155 5573.8 ± 41.6 188275.6 ± 361.1
NOXA 2343 ± 244.3 8293.3 ± 197.1 604.1 ± 125.8 59.9 ± 19.1 41774.2 ± 75.4
NOXO 9403.3 ± 382.2 40677.7 ± 220.4 6299.3 ± 195.9 5921.7 ± 41.63 219677.5 ± 426.8
DKOA 4591.6 ± 256.6 11783.1 ± 284.5 562.9 ± 183.7 32.9 ± 45.7 65974.3 ± 344.3
DKOO 9262.1 ± 342.7 41278.3 ± 361.7 7103.1 ± 201.6 6012.2 ± 59.7 197822.7 ± 388.7
Decrease in clonogenic potential in bone marrow and lung of both KO mice post-OVA. CFU (Colony Forming Units) as assay was done as described in Materials
and Methods and assayed in duplicate petridishes per sample. The results shown are pooled from three independent experiments (n = 5/group) ± SEM.
Abbreviations used are: BM, bone marrow; PB, peripheral blood, LP, lung parenchyma, BALf, bronchoalveolar lavage fluid. The total number of progenitors was
extrapolated to the total number cells obtained from each tissue. Underlined numbers denote p value < 0.01 compared to post-OVA WT.
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Page 8 of 14p47phox,p 6 7 phox, Rac2) and membrane compartments
(flavocytochrome b558, Rap1A). During phagocytosis,
the cytosolic components translocate to the plasma and/
or phagosome membrane and associate with flavocyto-
chrome b558, a transmembrane heterodimer comprised
of gp91phox (Nox2) and p22phox,t h e r e b yf o r m i n gt h e
active oxidase. The oxidase transfers electrons from
cytosolic NADPH to intraphagosomal molecular oxygen,
thus producing superoxide. Superoxide anion is short-
lived and dismutates rapidly to hydrogen peroxide and
forms other secondary products, such as hypochlorous
acid, hydroxyl radical, and singlet oxygen, which are
effective microbicidal compounds [16].
Briefly, deletion of gp91
phox results in enhancement of
composite asthma phenotype in mouse. Double deletion
of gp91phoix and MMp12, a critical enzyme for phago-
cyte associated inflammation results in no alteration of
the phenotype generated in the single deletion of
gp91phox-/-. Overall inflammation is robust. Both naïve
and allergen challenged KO mice show statistically sig-
nificant exacerbation of Th2 inflammation. All the clas-
sical features of a robust acute allergenic asthma
phenotype are significantly amplified in the KO mice
showing that NADPH oxidase, which is essentially an
extra-cellualr matrix associated enzyme expressed by
phagocytes, which by definition may denote a non-speci-
fic inflammatory response or at the best an inflamma-
tory phenomenon associated with lung remodeling in
chronic asthma, surprisingl ym a ya l s oh a v ear e g u l a t o r y
role in the sensitization or priming stage. This is no
more apparent than in the level of circulating and tissue
bound progenitors which show a clear mobilization
denoted by the dearth of stem as well as mature cells in
bone marrow. Because of the absence of gp91phox, the
cells seem to have less of an adherence to the stroma
and migrate out of their niche. The cellular traffic out
of bone marrow (CFU in femur was assessed) also
shows a more robust lympho- and eosinophilopoiesis.
Does gp91phox have any known role in hematopoiesis
or granulocytopoiesis? [16] says that NADPH essentially
increases neutrophil and eosinophil synthesis and migra-
tion to inflammatory tissues. If gp91phox is imagined to
have a regulatory role in development of the asthma
phenmotype, MMP12 seems to have a similar if not
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Figure 4 Clonogenic potential was decreased in the bone marrow and lung progenitors of both knockout mice post OVA.1 0m l
heparinized whole peripheral blood (PB) obtained by infra-orbital bleeding of anesthetized mouse, 50,000 bone marrow cells (BMC)flushed out
of the femurs, 1 million lung parenchyma (LP) cells digested by collagenase IV, 1 million cells from bronchoalveolar lavage fluid (BALf)and
500,000 cells from spleen was plated in 2 ml semi solid methyl cellulose medium and cultured for 7 d for PB, BM and spleen and for 14d for LP
and BALf. Colony forming units (CFU) was counted manually on a Leica DMIL and an Olympus sZX12 inverted microscope. Results shown are
pooled from three independent experiments (n = 5/group) ± SEM. * denotes p value < 0.01 compared to post-OVA wildtype values.
Abbreviations used are: WT = wildtype, NOX = gp91phox-/-, DKO = gp91phox-MMP12 double knockout, WA = WT+alum, WO = WT+OVA, NOXA
= gp91phox-/-+alum, NOXO = gp91phox-/-+OVA, DKOA = gp91phox-MMP12 double knockout+alum, DKOO = gp91phox-MMP12 double
knockout+OVA.
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Page 9 of 14synergistic effect. These molecules are however not
necessary for migration, but are critical for PMA
induced proliferation and MCP-1 induced chemotaxis.
The overall Th2 response was enhanced possibly due to
a lack of control over T cell: APC cross-talk in the KO
mice as shown by MLR.
The results described above indicate that gp91phox-/-
mice respond to OVA in a more exaggerated fashion
compared to WT post-OVA, in terms of total number of
cells migrated to lung (1.8 folds) and BALf (1.7 folds),
although total number of cells in bone marrow (obtained
from two femurs) and that in circulating peripheral blood
were comparable (Table 1). Expressed as a fraction of cir-
culating cells recruited into lungs and BALf in response
to allergic immune response, both knockout mice seem
to show similar trends. Cell subsets for which recruit-
m e n ti n d e xi sm o r et h a n1 ,i n d i c a t eac u m u l a t i v ee f f e c t
where both cells from circulation as well as resident cells
normally present in the pulmonary milieu in surveillance,
seem to be equally important. Recruitment of B cells,
monocytes, neutrophils and basophils are increased in
lungs of both knockout mice compared to post-OVA
wildtype while that of T cells, neutrophils and basophils
in BALf are increased in the knockout vs. the OVA-trea-
ted wildtype (Table 1). In gp91phox-/- progenitors in BM
decrease by 28.8% while in double knockout, it decreases
by 27.9% compared to the values in WT post-OVA. In
lung, the decrease in progenitor number was 1.8-fold and
1.5-fold respectively. NOX2 and DKO mice both show
spontaneous pulmonary inflammation. In naïve mouse,
this may account for the decrease in cell number in
femur and lungs (due to rapid and uncontrolled mobili-
zation out of the niche and out of the parenchyma into
the interstitium respectively. Spleen, because of this con-
stant and uncontrolled inflammatory background natu-
rally becomes inflamed and shows an increase in size and
cell number. Under treatment with allergen, this scenario
gets further aggravated. Femur (bone marrow) has been
B 
Wild type  gp91phox-/- gp91phox-/-MMP12-/-
A. 
B. 
C. 
Figure 5 Both knockout mice show increased inflammation and mucus secretion post OVA compared to WT. Paraffin sections of lungs
of OVA-treated mice were stained with A, Hematoxyline and eosin (10×), B. with Masson’s Trichrome stain (20×), and C. Alcian blue
counterstained with eosin (10×). Sections were viewed with a BX4l Olympus microscope and photomicrographs taken with a Nikon Spot digital
camera. Inflammatory cell migration was more pronounced around airways in the OVA-treated knockout mice compared to control.
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Page 10 of 14known to be the main pool of progenitors for granulopoi-
esis (PMNs and eosinophils). Cells from the lung par-
enchyma, on the other hand, need to migrate into the
interstitium for Th2 category inflammation in the lung
tissue. These may account for dearth of progenitors and
mature cells in these tissues while spleen registered a
higher than normal cell number anyway in these mice
and under a heightened condition of inflammatory
exacerbations, shows a higher reserve despite this
limitation.
My work [17-22] in conjunction with other work in
the public domain using genetic knockout models of
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Figure 6 Increase in percent alcian blue positive cells (goblet cell metaplasia) in gp91phox-/- and gp91phox-MMP12 double knockout
(DKO) post-OVA compared to wildtype (WT) post-OVA. Metaplastic goblet cells were counted as the blue cells stained positive by alcian
blue. Percent metaplastic goblet cells is calculated from the total number of cells counted around each airway. Abbreviations used are: WT =
wildtype, NOX = gp91phox-/-, DKO = gp91phox-MMP12 double knockout, WA = WT+alum, WO = WT+OVA, NOXA = gp91phox-/-+alum, NOXO
= gp91phox-/-+OVA, DKOA = gp91phox-MMP12 double knockout+alum, DKOO = gp91phox-MMP12 double knockout+OVA. The results shown
are pooled from 3 independent experiments. Counts were taken and averaged over 10 high power fields. Slides were counted on a Spencer AO
light microscope at 40 × magnification. Results are expressed as percent ± SEM. n = 5 animals/group. * denotes p value < 0.01 compared to
post-OVA wildtype values.
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Figure 7 Cytokine concentration in BALf. The concentration of cytokines in BALf was measured by outsourcing to Linco by multiplexing
technique in a luminometer. Data expressed here are mean ± SEM. n = 5/group. While all other Th2 cytokine levels were comparable to WT
+OVA, IL-13 concentration was increased 2.7-fold over post-OVA WT values. Abbreviations used are: WT = wildtype, NOX = gp91phox-/-, DKO =
gp91phox-MMP12 double knockout, WA = WT+alum, WO = WT+OVA, NOXA = gp91phox-/-+alum, NOXO = gp91phox-/-+OVA.
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Page 11 of 14mice in a preclinical set up to study molecular roles of
deleted molecules in the pathogenesis of acute allergic
asthma has revealed the following. The alternately deli-
cate and robust interplay of sensitization-priming vs.
fully activated state of cells play a crucial role in the
final translation of the pathogenesis status of the animal.
In humans Chronic granulomatous disease (CGD)
where is a group of inherited disorders in which phago-
cytes are unable to generate superoxide due to genetic
d e f e c t si na n y1o f4e s s e n t ial NADPH oxidase compo-
nents. Mutations in the X-linked gene for gp91phox, the
large subunit of the flavocytochrome b558 heterodimer,
account for the majority of CGD. Patients with CGD
develop recurrent, often life-threatening bacterial and
fungal infections due to impaired microbicidal oxidant
generation by the patient’s phagocytes. ROS are also
important in inducing in schemia-induced lung angio-
genesis. [23] gp91
phox, expressed in CHO (Chinese ham-
ster ovary) cells, functions as a voltage-dependent
proton channel. [24] gp91phox was also found to regu-
late adaptive immune response at the level of both T
cells and APCs [25].
Activation of NADPH oxidase represents an essential
mechanism of defense against pathogens. Dendritic cells
(DC) are phagocytic cells specialized in Ag presentation
rather than in bacteria killing. Human monocyte-derived
DC were found to express the NADPH oxidase
components and to release superoxide anions in
response to phorbol esters and phagocytic agonists. The
NADPH oxidase components p47phox and gp91phox
were down-regulated during monocyte differentiation to
DC, and maturation of DC with pathogen-derived mole-
cules, known to activate TLRs, increased p47phox and
gp91phox expression and enhanced superoxide anions
release. Similar results were obtained with plasmacytoid
DC following maturation with influenza virus. In con-
trast, activation of DC by immune stimuli (CD40 ligand)
did not regulate NADPH oxidase components or
respiratory burst. NADPH oxidase-derived oxygen radi-
cals did not play any role in DC differentiation, matura-
tion, cytokine production, and induction of T cell
proliferation, as based on the normal function of DC
generated from chronic granulomatous disease patients
and the use of an oxygen radical scavenger. However,
NADPH oxidase activation was required for DC killing
of intracellular Escherichia coli. It is likely that the selec-
tive regulation of oxygen radicals production by patho-
gen-activated DC may function to limit pathogen
dissemination during DC trafficking to secondary lym-
phoid tissues [26]. Reactive oxygen species (ROS) play
an important role in regulating vascular tone and intra-
cellular signaling [27].
In summary, the work presenetd in this communica-
tion describes in detail, the phenotype expressed in two
OVA-specific IgE and IgG1 levels in WT vs. NOX2-/- 
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Figure 8 Plasma concentrations of OVA-specific IgE and IgG1 are comparable between Wt and KO mice post-OVA. OVA-specific IgE and
IgG1 were measured by standard ELISA using a capture and a detection antibody for each of the immunoglobulins. Data showed represents
mean of values pooled from three independent experiments (n = 5/group). Abbreviations used are: WT = wildtype, NOX = gp91phox-/-, DKO =
gp91phox-MMP12 double knockout, WO = WT+OVA, NOXO = gp91phox-/-+OVA, DKOO = gp91phox-MMP12 double knockout+OVA. Levels of
OVA-specific cytokines in the alum treated corresponding control groups was undetectable.
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Page 12 of 14genotype knockout mice, gp91phox-/- and gp91phox,
MMP-12 double knockout. The data obtained indicates
clearly the following:
1. All aspects of acute allergic asthma are manifested
in an exaggerated manner in the knockout mice vs.
the WT, viz. cell recruitment is more, inflammatory
cell recruitment,, specifically myeloid cells in
increased; T cells are also recruited not only in
greated numbers but are also directly involved in the
disease pathogenesis by clearly increasing TH2 cyto-
kines, antigen-specific IgG and hypertrophy and
hyperplasia in goblet cells of the lung. So these
molecules seem to have regulatory roles in (a) cell
priming, (b) direct cell activation, and (c) cell
recruitment (which may include synthesis, mobiliza-
tion and homing out of their niches) and by extrapo-
lation, dendritic cells, phagocytes (macrophage and
neutrophils) and T cells in the afferent arm of the
disease pathology and eosinophils, B cells as denoted
by Ig sequestration and probably endothelial and
smooth muscle cells of the lung as well, in the effer-
ent arm (responsible for exacerbations) may be
defined as components under direct regulation of
these two molecules (gp91phox and MMP-12).
2. While gp91phox and MMP12 deletion affects the
mature cell polulation thus, the progenitor numbers
are also similarly affected. This possibly alludes to
greated synthesis in bone marrow or adult tissue
reserves as well as enhanced mobilization. This is an
important finding as it provides a critical link
between the actual increase in cell number and a
decreased adhesion to stroma thereby setting the
stage of more efficient mobilization. While gp91phox
and MMP12 interaction have been known to orches-
trate ROS activity and tissue damage during
inflammtion, there was no information regarding the
upstream implication between this manifestation of
innate immunity and the actual mechanistic phe-
nomenon encouraging cells to actually migrate in
larger numbers and more quickly to tissue spaces.
Whether this also aids specific tissue homing is
unknown at the present time and needs more work
in this model.
3. The function of gp91phox may be primary in
these regulatory cascade and MMP-12 may come in
later. However, based on the data presented in this
study, they seem to have synergistic or at best
redundant, but definitely not additive roles.
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